Katharina F. Kriechbaum

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

First-Line Faricimab in Diabetic Macular Edema: Insights from a Real-World Treatment-Naïve Population in Austria.

First-Line Faricimab in Diabetic Macular Edema: Insights from a Real-World Treatment-Naïve Population in Austria.

Journal: Journal of clinical medicine

Published: April 09, 2026

Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema.

Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema.

Journal: Investigative ophthalmology & visual science

Published: December 31, 2024

IOL decentration sensitivity according to spatial frequencies.

IOL decentration sensitivity according to spatial frequencies.

Journal: BMJ open ophthalmology

Published: January 30, 2024

Through-Focus Response of Extended Depth of Focus Intraocular Lenses.

Through-Focus Response of Extended Depth of Focus Intraocular Lenses.

Journal: Journal of refractive surgery (Thorofare, N.J. : 1995)

Published: August 10, 2022

Comparison of safety and effectiveness between 23-gauge and 25-gauge vitrectomy surgery in common vitreoretinal diseases.

Comparison of safety and effectiveness between 23-gauge and 25-gauge vitrectomy surgery in common vitreoretinal diseases.

Journal: PloS one

Published: December 07, 2020

Longitudinal analysis of microvascular perfusion and neurodegenerative changes in early type 2 diabetic retinal disease.

Longitudinal analysis of microvascular perfusion and neurodegenerative changes in early type 2 diabetic retinal disease.

Journal: The British journal of ophthalmology

Published: June 24, 2020

Association of macular perfusion status with microvascular parameters up to the far periphery in diabetic retinopathy using multimodal imaging.

Association of macular perfusion status with microvascular parameters up to the far periphery in diabetic retinopathy using multimodal imaging.

Journal: International journal of retina and vitreous

Published: June 15, 2020

Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One Year.

Response of Retinal Sensitivity to Intravitreal Anti-angiogenic Bevacizumab and Triamcinolone Acetonide for Patients with Diabetic Macular Edema over One Year.

Journal: Current eye research

Published: January 22, 2020

Posterior capsule opacification and Nd:YAG laser rates with two hydrophobic acrylic single-piece IOLs.

Posterior capsule opacification and Nd:YAG laser rates with two hydrophobic acrylic single-piece IOLs.

Journal: Eye (London, England)

Published: February 07, 2019

Reply.

Reply.

Journal: Retina (Philadelphia, Pa.)

Published: August 12, 2017

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: June 30, 2017

COMPARISON OF GANGLION CELL INNER PLEXIFORM LAYER THICKNESS BY CIRRUS AND SPECTRALIS OPTICAL COHERENCE TOMOGRAPHY IN DIABETIC MACULAR EDEMA.

COMPARISON OF GANGLION CELL INNER PLEXIFORM LAYER THICKNESS BY CIRRUS AND SPECTRALIS OPTICAL COHERENCE TOMOGRAPHY IN DIABETIC MACULAR EDEMA.

Journal: Retina (Philadelphia, Pa.)

Published: April 05, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026